Ludwig-Maximilians-Universität (LMU)

Health-related quality of life (HRQoL) in CML-patients at diagnosis compared to general population (2021) Lorch M, Pfirrmann M, Fabisch C, Oberle L, Kohn D, Kohlbrenner K, Bruemmendorf TH, et al. Conference contribution Status report on the atopic dermatitis registry TREATgermany Statusbericht zum Neurodermitisregister TREATgermany (2021) Siegels D, Haufe E, Heinrich L, Werfel T, Weidinger S, Schmitt J, Abraham S, et al. Journal article, Review article Current clinical practice of prenatal dexamethasone treatment in at risk pregnancies for classic 21-hydroxylase deficiency in Europe (2021) Nowotny HF, Neumann U, Tardy-Guidollet V, Ahmed SF, Baronio F, Battelino T, Bertherat J, et al. Conference contribution Launch of a national candidemia surveillance network in Germany (2021) Aldejohann AM, Reinhardt M, Martin R, Walther G, Elias J, Haas A, Hamprecht A, et al. Conference contribution Evaluation of INSTAND e.V.'s external quality assessment for Cryptococcus antigen testing autumn 2016-spring 2021 (2021) Wilmes D, Heckmann D, Ehrhard I, Schaumburg F, Dichtl K, Schoerner C, Mccormick-Smith I, Rickerts V Conference contribution Clinical Prognostic Factors in metastatic Choroidal Melanoma (2021) Koch E, Petzold A, Wessely A, Dippel E, Erdmann M, Heinzerling L, Hohberger B, et al. Conference contribution The Side Effect Registry SERIO - Side Effect Registry Immuno-Oncology - documenting, analyzing and better understanding Complex Side Effects under Immunotherapy (2021) Zierold S, Rahimi F, Kramer R, Knauss S, Tomsitz D, French LE, Heinzerling L Conference contribution Development of a digital Teaching Project on the Topic of "Immunooncology" (2021) Kaufmann M, Berking C, French LE, Meyerolbersleben M, Reinholz M, Steeb T, Heppt M Conference contribution Serositis in Association with System Therapy with Checkpoint Inhibitors - More frequent than thought? - An Evaluation of the SERIO Adverse Event Registry (2021) Zierold S, Kramer R, Erdmann M, Akcetin SL, Maier AM, Koenig A, Theurich S, et al. Conference contribution Investigation on Consequences of Autoimmunity with Regard to Quality of Life in Patients with Checkpoint Inhibitor Therapy compared to Patients with Autoimmune Disease (2021) Schulz TU, Zierold S, Akcetin SL, Pesch G, French LE, Heinzerling L Conference contribution